Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

FMRP targets distinct mRNA sequence elements to regulate protein expression

Abstract

Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1−/− mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: PAR-CLIP of FMR1-family proteins.
Figure 2: Analysis of FMR1-family protein mRNA-binding sites.
Figure 3: RNA-binding assays using natural FMRP target sites containing ACUK and WGGA RREs, and the effect of a KH2 mutation to its target RNA spectrum.
Figure 4: RRE-dependent enrichment criteria for FMRP association with mRNAs.
Figure 5: Ovarian phenotype in Fmr1 −/ mice.

Accession codes

Primary accessions

Gene Expression Omnibus

Data deposits

Data sets have been submitted to gene expressionomnibus (GEO) under the accession code GSE39686

References

  1. Verkerk, A. J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914 (1991)

    Article  CAS  Google Scholar 

  2. Kremer, E. J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711–1714 (1991)

    Article  ADS  CAS  Google Scholar 

  3. Vincent, A. et al. Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature 349, 624–626 (1991)

    Article  ADS  CAS  Google Scholar 

  4. Siomi, H., Siomi, M. C., Nussbaum, R. L. & Dreyfuss, G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74, 291–298 (1993)

    Article  CAS  Google Scholar 

  5. Ashley, C. T. J., Wilkinson, K. D., Reines, D. & Warren, S. T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563–566 (1993)

    Article  ADS  CAS  Google Scholar 

  6. Brown, V. et al. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem. 273, 15521–15527 (1998)

    Article  CAS  Google Scholar 

  7. Darnell, J. C. et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489–499 (2001)

    Article  CAS  Google Scholar 

  8. Ashley, C. T. et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genet. 4, 244–251 (1993)

    Article  CAS  Google Scholar 

  9. Verkerk, A. J. et al. Alternative splicing in the fragile X gene FMR1 . Hum. Mol. Genet. 2, 399–404 (1993)

    Article  CAS  Google Scholar 

  10. De Boulle, K. et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet. 3, 31–35 (1993)

    Article  CAS  Google Scholar 

  11. Siomi, H., Choi, M., Siomi, M. C., Nussbaum, R. L. & Dreyfuss, G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77, 33–39 (1994)

    Article  CAS  Google Scholar 

  12. Feng, Y. et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109–118 (1997)

    Article  CAS  Google Scholar 

  13. Fridell, R. A., Benson, R. E., Hua, J., Bogerd, H. P. & Cullen, B. R. A nuclear role for the Fragile X mental retardation protein. EMBO J. 15, 5408–5414 (1996)

    Article  CAS  Google Scholar 

  14. Ling, S. C., Fahrner, P. S., Greenough, W. T. & Gelfand, V. I. Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc. Natl Acad. Sci. USA 101, 17428–17433 (2004)

    Article  ADS  CAS  Google Scholar 

  15. Davidovic, L. et al. The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum. Mol. Genet. 16, 3047–3058 (2007)

    Article  CAS  Google Scholar 

  16. Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H. & Bassell, G. J. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14, 926–939 (2008)

    Article  CAS  Google Scholar 

  17. Corbin, F. et al. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6, 1465–1472 (1997)

    Article  CAS  Google Scholar 

  18. Oostra, B. A. & Willemsen, R. FMR1: a gene with three faces. Biochim. Biophys. Acta 1790, 467–477 (2009)

    Article  CAS  Google Scholar 

  19. De Rubeis, S., Fernández, E., Buzzi, A., Di Marino, D. & Bagni, C. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. Adv. Exp. Med. Biol. 970, 517–551 (2012)

    Article  CAS  Google Scholar 

  20. Gross, C., Berry-Kravis, E. M. & Bassell, G. J. Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology 37, 178–195 (2012)

    Article  CAS  Google Scholar 

  21. Hagerman, R., Lauterborn, J., Au, J. & Berry-Kravis, E. Fragile X syndrome and targeted treatment trials. Results Probl. Cell Differ. 54, 297–335 (2012)

    Article  CAS  Google Scholar 

  22. Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011)

    Article  CAS  Google Scholar 

  23. Krueger, D. D. & Bear, M. F. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med. 62, 411–429 (2011)

    Article  CAS  Google Scholar 

  24. Pfeiffer, B. E. & Huber, K. M. The state of synapses in fragile X syndrome. Neuroscientist 15, 549–567 (2009)

    Article  CAS  Google Scholar 

  25. Belmonte, M. K. & Bourgeron, T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neurosci. 9, 1221–1225 (2006)

    Article  CAS  Google Scholar 

  26. Brown, V. et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477–487 (2001)

    Article  CAS  Google Scholar 

  27. Bassell, G. J. & Warren, S. T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201–214 (2008)

    Article  CAS  Google Scholar 

  28. Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141 (2010)

    Article  CAS  Google Scholar 

  29. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464–469 (2008)

    Article  ADS  CAS  Google Scholar 

  30. Ascano, M., Hafner, M., Cekan, P., Gerstberger, S. & Tuschl, T. Identification of RNA–protein interaction networks using PAR-CLIP. Wiley Interdiscip. Rev. RNA 3, 159–177 (2012)

    Article  CAS  Google Scholar 

  31. Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA 101, 6062–6067 (2004)

    Article  ADS  CAS  Google Scholar 

  32. Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008)

    Article  ADS  CAS  Google Scholar 

  33. Kishore, S. et al. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nature Methods 8, 559–564 (2011)

    Article  CAS  Google Scholar 

  34. Corcoran, D. L. et al. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol. 12, R79 (2011)

    Article  CAS  Google Scholar 

  35. Georgiev, S. et al. Evidence-ranked motif identification. Genome Biol. 11, R19 (2010)

    Article  Google Scholar 

  36. Westmark, C. J. & Malter, J. S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 5, e52 (2007)

    Article  Google Scholar 

  37. Schaeffer, C. et al. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20, 4803–4813 (2001)

    Article  CAS  Google Scholar 

  38. Ceman, S., Brown, V. & Warren, S. T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19, 7925–7932 (1999)

    Article  CAS  Google Scholar 

  39. Bhakar, A. L., Dölen, G. & Bear, M. F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012)

    Article  CAS  Google Scholar 

  40. Greer, P. L. et al. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704–716 (2010)

    Article  CAS  Google Scholar 

  41. Bakker, C. E. et al. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch–Belgian Fragile X Consortium. Cell 78, 23–33 (1994)

    Google Scholar 

  42. Gross, C. et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J. Neurosci. 30, 10624–10638 (2010)

    Article  CAS  Google Scholar 

  43. Sharma, A. et al. Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 30, 694–702 (2010)

    Article  CAS  Google Scholar 

  44. Auerbach, B. D., Osterweil, E. K. & Bear, M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011)

    Article  ADS  CAS  Google Scholar 

  45. Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L. & Sabatini, B. L. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. 31, 8862–8869 (2011)

    Article  CAS  Google Scholar 

  46. Chévere-Torres, I. et al. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Neurobiol. Dis. 45, 1101–1110 (2012)

    Article  Google Scholar 

  47. Hoell, J. et al. in Handbook of RNA Biochemistry Vol. 1 (eds Hartmann, R.K., Bindereif, A., Schön, A. & Westhof, E. ) (Wiley-VCH, 2013)

  48. Mahony, S., Auron, P. E. & Benos, P. V. DNA familial binding profiles made easy: comparisons of various motif alignment and clustering strategies. PLoS Comp. Biol. 3, e61 (2007)

    Article  ADS  MathSciNet  Google Scholar 

  49. Landthaler, M. et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14, 2580–2596 (2008)

    Article  CAS  Google Scholar 

  50. Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–315 (2004)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. We would like to thank the following members of the Tuschl laboratory for their support and assistance: G. Wardle, N. Renwick and I. Ben-Dov. We would like to thank J. Keene for his advice throughout the project. We would like to acknowledge M. Khorshid, L. Burger and M. Zavolan for analysing PAR-CLIP data at the initial stages of the project and discussions. We would like to thank the Memorial Sloan-Kettering Cancer Center in-situ core for their assistance with the mouse histology. Finally, we would like to express our appreciation to all members of the Tuschl laboratory for their assistance and collegiality. This work was supported, in part, by the following agencies: NIH/NCRR/RU CCTS (M.A., UL1RR024143), NSF (U.O., MCB-0822033), Simons Foundation Autism Research Initiative (T.T., CEN5300891) and NIH (T.T., R01 MH080442; Z.W., K08 HD068546).

Author information

Authors and Affiliations

Authors

Contributions

M.A. designed, executed, supervised and interpreted experiments. N.M., P.B. and D.L.C. carried out the sequence alignment, annotation and PARalyzer pipeline. N.M. and P.B. performed the computational analysis on the RIP-chip. M.A., J.B.M. and J.D.N. purified FMRP proteins, performed the EMSAs and carried out the quantitative western blots and analyses. M.A. and M.M. performed the RIP-chips. S.D. assisted in the Illumina sequencing of all PAR-CLIP libraries. M.H. helped in the initial PAR-CLIP experiments. C.L. and Z.W. carried out and analysed mouse experiments. U.O. supervised computational efforts. T.T. supervised and helped in the design of experiments. M.A. and T.T. wrote the manuscript.

Corresponding authors

Correspondence to Uwe Ohler or Thomas Tuschl.

Ethics declarations

Competing interests

T.T. is co-founder and scientific advisor to Alnylam Pharmaceuticals and Regulus Therapeutics.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-10. (PDF 6330 kb)

Supplementary Data

This zipped file contains Supplementary Tables 1 and 3-7. (ZIP 4835 kb)

Supplementary Data

This zipped file contains Supplementary Tables 2a and 2b. (ZIP 28742 kb)

Supplementary Data

This zipped file contains Supplementary Tables 2c and 2d. (ZIP 25222 kb)

Supplementary Data

This zipped file contains Supplementary Table 2e. (ZIP 12798 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ascano, M., Mukherjee, N., Bandaru, P. et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492, 382–386 (2012). https://doi.org/10.1038/nature11737

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature11737

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research